ADHD in New York
ADHD Treatment Study
Dr. Jeffrey Newcorn and his team at the Clinical Trials Program are evaluating brain activation in response to Guanfacine, a medication used in the treatment of ADHD.
Please call if your child is between 8-15 years of age and experiences symptoms of ADHD like being easily distracted, making careless mistakes, being forgetful in daily activities, having difficulty paying attention, and difficulty organizing.
Your child will receive at no cost: a comprehensive psychiatric and physical screening to determine whether he or she has ADHD and is healthy enough to be treated with medication; pre and post treatment fMRI scanning; weekly visits with our physicians; up to 2 months of medication (either during the trial or, if assigned to placebo, after 6 to 8 weeks of participation); referral for on-going care with progress report of participation.
The study lasts up to 9 weeks, but you may choose to see our doctors at no cost for up to 2 additional months while your child is stabilized on the medication that works best for him or her.
Reimbursement is available to participants and their parents.
If we do not have a research study that is right for you at this time, we can refer you with other options and/or contact you for future studies. Mount Sinai is located on the Upper East Side of Manhattan.
GCO# 09-1825. IRB Approved: 11/3/2013-11/2/2014.
Contact: Beth Krone PhD
Top 5 This Month
ADDitude's most popular articles
Free Accommodations Booklet
Important! User-Generated Content
The opinions expressed on ADDConnect are solely those of the user, who may or may not have medical training. These opinions do not represent the opinions of ADDConnect or ADDitude magazine. For more information, see our terms and conditions.